We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Pharmacokinetics of Commonly Used Antimicrobials in Critically Ill Adults During Extracorporeal Membrane Oxygenation: A Systematic Review.
- Authors
Duceppe, Marc-Alexandre; Kanji, Salmaan; Do, Anh Thu; Ruo, Ni; Cavayas, Yiorgos Alexandros; Albert, Martin; Robert-Halabi, Maxime; Zavalkoff, Samara; Dupont, Patrice; Samoukovic, Gordan; Williamson, David R.
- Abstract
Purpose: Adequate dosing of antimicrobials is critical to properly treat infections and limit development of resistance and adverse effects. Limited guidance exists for antimicrobial dosing adjustments in patients requiring extracorporporeal membrane oxygenation (ECMO) therapy. A systematic review was conducted to delineate the pharmacokinetics (PK) and pharmacodynamics (PD) of antimicrobials in critically ill adult patients requiring ECMO. Methods: Medline, EMBASE, Global Health, and All EBM Reviews databases were searched. Grey literature was examined. All studies reporting PK/PD parameters of antimicrobials in critically ill adults treated with ECMO were included, except for case reports and congress abstracts. Ex vivo studies were included. Two independent reviewers applied the inclusion and exclusion criteria. Reviewers were then paired to independently abstract data and evaluate methodological quality of studies using the ROBINS-I tool and the compliance with ClinPK guidelines. Patients' and studies' characteristics, key PK/PD findings, details of ECMO circuits and co-treatments were summarized qualitatively. Dosing recommendations were formulated based on data from controlled studies. Results: Thirty-two clinical studies were included; most were observational and uncontrolled. Fourteen ex vivo studies were analysed. Information on patient characteristics and co-treatments was often missing. The effect of ECMO on PK/PD parameters of antimicrobials varied depending on the studied drugs. Few dosing recommendations could be formulated given the lack of good quality data. Conclusion: Limited data exist on the PK/PD of antimicrobials during ECMO therapy. Rigorously designed and well powered populational PK studies are required to establish empiric dosing guidelines for antimicrobials in patients requiring ECMO support. PROSPERO Registration Number: CRD42018099992 (Registered: July 24th 2018).
- Subjects
MEDICAL information storage &; retrieval systems; CRITICALLY ill; SYSTEMATIC reviews; ANTI-infective agents; PATIENTS; EXTRACORPOREAL membrane oxygenation; MEDLINE; PHARMACODYNAMICS
- Publication
Drugs, 2021, Vol 81, Issue 11, p1307
- ISSN
0012-6667
- Publication type
Article
- DOI
10.1007/s40265-021-01557-3